^
    Apply
    A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor (NCT04797468)
    Phase 1
    Shanghai Henlius Biotech
    Withdrawn
    Last update posted :
    01/16/2023
    Initiation :
    07/18/2022
    Primary completion :
    01/13/2023
    Completion :
    01/13/2023
    CD68
    |
    HLX23